课题基金 / 基金详情

Cell Interactions in Three Dimensional Tissue Culture

Cell Interactions in Three Dimensional Tissue Culture
三维组织培养中的细胞相互作用
批准号:
8149276
负责人:
Leonid B. Margolis
金额:
$154.86万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Leonid B. Margolis的其他基金

相似基金

相关文献

中文摘要
翻译
选择性传播R5 HIV-1变种,把关X4 HIV-1。 为了进入靶细胞,HIV-1使用CD4和在体内是CCR5(针对R5 HIV变种)或CXCR4(针对X4 HIV-1变种)的辅助受体。虽然R5和X4 HIV-1变种都存在于体液(精液、血液、宫颈阴道和直肠分泌物)中,但几乎完全是如此,R5 HIV-1似乎传播感染,并主导艾滋病毒疾病的早期阶段。此外,最近的序列分析表明,在大多数病例中,单一病毒引发了感染。因此,存在选择R5而不是X4 HIV-1的看门人,并且可以在R5 HIV-1变种中操作以选择单个变种。仔细分析与每条传播途径相关的这种潜在的把关机制表明,它们太不完美了,无法解释为什么在艾滋病毒传播中几乎完美地选择了R5而不是X4。我们建议,不是一个强大的把关人,而是许多弱的把关人,它们的叠加足以防止X4HIV-1感染,并有可能从R5HIV-1变异体库中选择可传播的变种。综上所述,我们认为多障碍原理更具一般性,并不局限于对X4HIV-1的保护,而是可以应用于一个因素比另一个因素具有选择性优势的其他现象(S)。就HIV-1传播的守门人而言,任务是识别这些因素并破译其分子机制。对守门人本地化和功能的了解可能使我们能够促进现有的针对R5传播的障碍,并针对所有HIV-1变种建立新的障碍。总体而言,了解HIV-1传播的把关机制对于制定有效的HIV-1预防措施(杀菌剂、病毒素和疫苗)至关重要。 HIV-1传播至宫颈阴道组织早期屏障的体外实验研究 由于宫颈阴道组织是HIV-1在异性传播过程中的第一个通道,女性下生殖道可能是第一个守门人,至少提供了对一些HIV-1变种的保护。利用手术切除的宫颈-阴道组织标本(可从商业上获得),我们开发了一个体外系统来研究HIV从男性到女性的阴道传播,并研究了该系统中的把关机制。了解这些机制需要对女性下生殖器粘膜细胞的表型和功能特征有充分的了解,这些都与艾滋病毒-1传播的早期事件有关。这种知识在已出版的文献中是缺乏的。使用原始的流式细胞术方案,我们发现在宫颈阴道组织中,CD4和CD8T细胞主要是高度分化的效应记忆表型,具有不同的激活标记表达模式。效应器记忆细胞在宫颈-阴道T细胞中的高度流行可能是高效防御各种传入病原体的关键。我们确定了优先感染HIV-1的CD4T细胞的表型以及激活和分化状态,HIV-1在体外传播到宫颈阴道组织。优先感染激活的CD38+CD4T细胞之后,未感染HIV-1的旁观者细胞也会被激活,从而在R5HIV-1复制和支持这种感染的细胞靶点数量之间形成恶性循环。这些结果为HIV-1感染的依赖性和宫颈阴道淋巴细胞活化的扩散提供了新的见解。值得注意的是,尽管X4和R5 HV-1的共同受体CXCR4和CCR5都广泛表达,但分离的宫颈阴道组织块保留了一种在R5和X4 HIV-1感染之间选择的体内把关机制。我们认为宫颈阴道组织对R5 HIV-1感染的敏感性高于X4 HIV-1感染,这是由于CD27+CD28+记忆效应CD4T细胞的低丰度所致。在体外宫颈-阴道组织系统中,我们现在正在研究为通过粘膜屏障传播感染的R5HIV-1病毒粒子选择的潜在屏障。 高危血清阴性人群中保护性屏障的决定因素 存在多种把关机制的理论和实验实验室证据需要转化为临床研究。越来越多的流行病学文献表明,有些人曾感染艾滋病毒,但仍未受感染。我们建议启动一项复杂的研究,通过使用一组被认为感染风险很高的未感染者来调查对艾滋病毒感染的天然抵抗力障碍。除了CCR5基因中32个碱基对的缺失,这是在本报告发表之日与高水平的艾滋病毒感染相关的唯一机制,这些队列还将允许研究替代的保护机制。根据我们的概念,一些不完美的守门人有助于防止感染。此外,这种保护可能不会随着时间的推移而保持一致,可能会受到各种因素的影响,如激素环境、先天和获得性免疫以及个体微生物群,因此,一个人表面上在一段高风险暴露期间受到保护,但在其他时间可能会失去这种相对保护。包括我们部门在内的一个实验室联盟已经成立,以确定体内的自然守门人。
英文摘要
Selective transmission of R5 HIV-1 variants, gatekeeping X4 HIV-1. To enter target cells, HIV-1 uses CD4 and a coreceptor that in vivo is either CCR5 (for R5 HIV-variants) or CXCR4 (for X4 HIV-1 variants). Although both R5 and X4 HIV-1 variants are present in body fluids (semen, blood, cervico-vaginal and rectal secretions), almost exclusively, R5 HIV-1 appears to transmit infection and dominates the early stages of HIV disease. Moreover, recent sequence analysis showed that a single virus initiates the infection in the majority of cases. Therefore, there is a gatekeeper that selects R5 over X4 HIV-1 and may operate among R5 HIV-1 variants to select a single variant. Careful analysis of such potential gatekeeping mechanisms associated with each of the transmission routes shows that they are too imperfect to explain the almost perfect selection of R5 over X4 in HIV transmission. We suggest that instead of one strong gatekeeper there are many weak ones, whose superimposition is sufficient to protect against X4 HIV-1 infection and potentially select transmittable variants from a pool of R5 HIV-1 variants. In conclusion, we think that the principle of multiple barriers is more general and not restricted to the protection against X4 HIV-1, but can be applied to other phenomena when one factor has a selective advantage over the other(s). In the case of gatekeepers for HIV-1 transmission, the task is to identify these factors and to decipher their molecular mechanisms. The knowledge of the gatekeepers localization and function may enable us to facilitate existing barriers against R5 transmission and to erect new ones against all HIV-1 variants. In general, understanding the gatekeeping mechanisms of HIV-1 transmission is critically important for the development of effective HIV-1-preventive measures (microbicides, virustats, and vaccines). Experimental study of the early barriers in HIV-1 transmission to cervico-vaginal tissue ex vivo As the cervico-vaginal tissue is the first gateway for HIV-1 during heterosexual transmission, the female lower genital tract may serve as the first gatekeeper, conferring protection against at least some HIV-1 variants. Using surgical samples of cervico-vaginal tissue (available commercially), we developed an ex vivo system to study HIV male-to-female vaginal transmission, and investigated the gatekeeping mechanisms in this system. Understanding these mechanisms requires a robust knowledge of the phenotypes, and of the functional features of the cells in the female lower genital mucosa, which are implicated in the early events of HIV-1 transmission. Such knowledge was lacking in the published literature. Using an original flow-cytometry protocol, we found that in the cervico-vaginal tissue, CD4 and CD8 T cells are predominantly of the highly differentiated effector memory phenotype with a variable pattern of expression of activation markers. The high prevalence of effector memory cells among cervico-vaginal T cells may be critical for the highly efficient defense against various incoming pathogens. We identified the phenotype, as well as the activation and differentiation status, of CD4 T cells that are preferentially infected by HIV-1 that is transmitted to cervico-vaginal tissue ex vivo. Preferential infection of activated CD38+ CD4 T cells was followed by a similar activation of HIV-1-uninfected bystander cells, creating a vicious circle between R5 HIV-1 replication and the number of cell targets that support this infection. These results provide new insights into the dependence of HIV-1 infection and the dissemination of the activation of cervico-vaginal lymphocytes. Remarkably, isolated blocks of cervico-vaginal tissue retain an in vivo gatekeeping mechanism that selects between R5 and X4 HIV-1 infection in spite of the broad expression of both CXCR4 and CCR5, the co receptors for X4 and R5 HV-1. We attributed the higher susceptibility of cervico-vaginal tissue to R5 HIV-1 infection over X4 HIV-1 infection, to the low abundance of the CD27+ CD28+ effector memory CD4 T cells. In the system of cervico-vaginal tissue ex vivo, we are now investigating potential barriers that select for the R5 HIV-1 virions that transmit infection through the mucosal barriers. Determinants of protective barriers among high-risk seronegative persons Theoretical and experimental laboratory evidences of the existence of multiple gatekeeping mechanisms need to be translated into clinical research. Growing epidemiological literature indicates that there are persons who have been exposed to HIV infection but who have remained uninfected. We suggest launching a complex study to investigate the natural barriers of resistance to HIV infection by using a cohort of uninfected persons where the risks for infection are thought to be high. In addition to the 32 base pair deletion in the CCR5 gene which, at the date of this report, is the only mechanism associated with a high protection level from HIV infection, these cohorts will allow the investigation of alternate mechanisms of protection. According to our concept a number of imperfect gatekeepers contribute to the protection from infection. Moreover, this protection may not be consistent over time, and may be affected by various factors such as hormonal environment, innate and adaptive immunity as well as the individuals microbiome so that an individual apparently protected for one period of high-risk exposure, may lose this relative protection at other times. A consortium of laboratories including our Section has been established to identify natural gatekeepers in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MORPHOLOGICAL DYNAMICS OF CELL DIFFERENTIATION
  • 批准号:
    2291917
  • 项目类别:
  • 资助金额:
    $6.49万
  • 财政年份:
    1995
  • 负责人:
    Leonid B. Margolis
  • 依托单位:
MORPHOLOGICAL DYNAMICS OF CELL DIFFERENTIATION
  • 批准号:
    2291919
  • 项目类别:
  • 资助金额:
    $0.25万
  • 财政年份:
    1995
  • 负责人:
    Leonid B. Margolis
  • 依托单位:
Cell Interactions in Three Dimensional Tissue Culture
Cell Interactions in Three Dimensional Tissue Culture
海外基金